Corporate governance
We believe in doing business the right way. And our policies and procedures support this ambition at every turn.
The next Annual General Meeting will take place on May 6, 2025 in Kaiseraugst, Switzerland.
The Annual General Meeting of DSM-Firmenich AG took place on 7 May 2024 at the company’s head offices at Wurmisberg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.
Approval of the stand-alone interim financial statements of DSM-Firmenich AG for the period from 1 January 2023 to 8 May 2023
| For | Against | Abstain | Total |
Votes | 195,384,208 | 1,200,493 | 879,797 | 197,464,498 |
% | 98.95% | 0.61% | 0.45% |
|
Dividend / Distribution of Capital Contribution Reserves
| For | Against | Abstain | Total |
Votes | 197,445,780 | 8,293 | 10,425 | 197,464,498 |
% | 99.99% | 0.00% | 0.01% |
|
Approval of remuneration for the Board of Directors
| For | Against | Abstain | Total |
Votes | 191,903,348 | 4,485,119 | 1,076,031 | 197,464,498 |
% | 97.18% | 2.27% | 0.54% |
|
Approval of the remuneration of the Executive Committee
| For | Against | Abstain | Total |
Votes | 191,489,400 | 4,476,258 | 1,498,840 | 197,464,498 |
% | 96.97% | 2.27% | 0.76% |
|
Approval of certain important transactions by shareholders
| For | Against | Abstain | Total |
Votes | 185,937,469 | 3,530,633 | 7,996,396 | 197,464,498 |
% | 94.16% | 1.79% | 4.05% |
|
Possibility of the Board of Directors to request custodians to disclose the identity of shareholders and beneficial owners
| For | Against | Abstain | Total |
Votes | 184,157,906 | 3,790,079 | 9,516,513 | 197,464,498 |
% | 93.26% | 1.92% | 4.82% |
|
Voting instructions can be provided through this link.
We would love to hear from you! If you have any questions, please contact us via e-mail button below.
We believe in doing business the right way. And our policies and procedures support this ambition at every turn.
Learn more about dsm-firmenich’s Policies, Procedures & Rules to prevent the misuse of inside information.
Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.